Why is Kwality Pharmaceuticals Ltd ?
- The company has declared positive results for the last 10 consecutive quarters
- PAT(Latest six months) At Rs 50.92 cr has Grown at 92.73%
- NET SALES(Latest six months) At Rs 319.46 cr has Grown at 40.63%
- OPERATING PROFIT TO INTEREST(Q) Highest at 15.42 times
- Institutional investors have increased their stake by 0.54% over the previous quarter and collectively hold 3.69% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
How much should you buy?
- Overall Portfolio exposure to Kwality Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
At Rs 50.92 cr has Grown at 92.73%
At Rs 319.46 cr has Grown at 40.63%
Highest at 15.42 times
Highest at 21.92%
Highest at 6.43 times
Highest at Rs 41.01 cr.
Highest at 25.26%
Highest at Rs 33.37 cr.
Highest at Rs 24.68
Lowest at Rs 3.59 cr
Lowest at 1.80 times
Here's what is working for Kwality Pharma
Operating Profit to Interest
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Net Sales (Rs Cr)
Operating Profit (Rs Cr)
Operating Profit to Sales
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Inventory Turnover Ratio
Net Sales (Rs Cr)
EPS (Rs)
Here's what is not working for Kwality Pharma
Cash and Cash Equivalents
Debtors Turnover Ratio






